Aflac (AFL)
(Delayed Data from NYSE)
$84.83 USD
+0.15 (0.18%)
Updated May 8, 2024 04:00 PM ET
After-Market: $84.85 +0.02 (0.02%) 7:56 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Aflac (AFL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$83.92 | $95.00 | $75.00 | -0.90% |
Price Target
Based on short-term price targets offered by 13 analysts, the average price target for Aflac comes to $83.92. The forecasts range from a low of $75.00 to a high of $95.00. The average price target represents a decline of 0.9% from the last closing price of $84.68.
Analyst Price Targets (13)
Broker Rating
Aflac currently has an average brokerage recommendation (ABR) of 2.93 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms. The current ABR compares to an ABR of 2.93 a month ago based on 14 recommendations.
Of the 14 recommendations deriving the current ABR, two are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 14.29% and 7.14% of all recommendations. A month ago, Strong Buy made up 14.29%, while Buy represented 7.14%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 9 | 9 | 9 | 9 | 9 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 2 | 2 | 2 | 2 | 2 |
ABR | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/2/2024 | Not Identified | Not Identified | Hold | Hold |
5/2/2024 | Truist Securities | Mark D Hughes | Hold | Hold |
4/10/2024 | Keefe Bruyette & Woods | Ryan Krueger | Hold | Hold |
3/28/2024 | Piper Sandler | John Barnidge | Strong Buy | Strong Buy |
2/2/2024 | Raymond James | Wilma Burdis | Moderate Buy | Moderate Buy |
1/4/2024 | Evercore Partners | Thomas Gallagher | Hold | Strong Sell |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.93 |
ABR (Last week) | 2.93 |
# of Recs in ABR | 14 |
Average Target Price | $83.92 |
LT Growth Rate | 5.80% |
Industry | Insurance - Accident and Health |
Industry Rank by ABR | 171 of 252 |
Current Quarter EPS Est: | 1.61 |